Evaluation of Purified Poloxamer 188 in Children in Crisis (EPIC): A Phase 3 randomized, double-blind, placebo-controlled, multicenter clinical trial of MSY-188 injection in children with Sickle Cell disease experiencing vaso-occlusive crisis.
Clinical Trial Grant
Administered By
Medicine, Hematology
Awarded By
: Mast Therapeutics, Inc.
Start Date
May 1, 2014
End Date
April 30, 2017
Administered By
Medicine, Hematology
Awarded By
: Mast Therapeutics, Inc.
Start Date
May 1, 2014
End Date
April 30, 2017